Ind-Swift Laboratories Limited (INDSWFTLAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.015x

Based on the latest financial reports, Ind-Swift Laboratories Limited (INDSWFTLAB) has a cash flow conversion efficiency ratio of -0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-202.50 Million ≈ $-2.19 Million USD) by net assets (Rs13.07 Billion ≈ $141.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Ind-Swift Laboratories Limited for the company's overall valuation and market capitalisation.

Ind-Swift Laboratories Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Ind-Swift Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ind-Swift Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ind-Swift Laboratories Limited ranked by their cash flow conversion efficiency. Explore Ind-Swift Laboratories Limited (INDSWFTLAB) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Guangdong Anjubao Digital Tech
SHE:300155
0.000x
LPKF Laser & Electronics AG
F:LPK
-0.091x
M-tron Industries, Inc.
NYSE MKT:MPTI
0.042x
Southern Score Builders Berhad
KLSE:0045
0.004x
Mobia Medical, Inc. Common Stock
NASDAQ:MOBI
0.106x
Jiangsu Chunlan Refrigerating Equipment Stock Co Ltd
SHG:600854
0.006x
Sichuan Tianwei Electronic Co Ltd
SHG:688511
-0.013x
Poongsan Holdi
KO:005810
0.011x

Annual Cash Flow Conversion Efficiency for Ind-Swift Laboratories Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. View Ind-Swift Laboratories Limited share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs11.73 Billion
≈ $126.85 Million
Rs-254.74 Million
≈ $-2.75 Million
-0.022x +89.19%
2024-03-31 Rs8.12 Billion
≈ $87.82 Million
Rs-1.63 Billion
≈ $-17.64 Million
-0.201x -170.38%
2023-03-31 Rs6.82 Billion
≈ $73.75 Million
Rs1.95 Billion
≈ $21.05 Million
0.285x +14.11%
2022-03-31 Rs6.01 Billion
≈ $64.98 Million
Rs1.50 Billion
≈ $16.25 Million
0.250x +11.83%
2021-03-31 Rs6.03 Billion
≈ $65.26 Million
Rs1.35 Billion
≈ $14.59 Million
0.224x +14.40%
2020-03-31 Rs6.41 Billion
≈ $69.28 Million
Rs1.25 Billion
≈ $13.54 Million
0.195x +278.44%
2019-03-31 Rs5.88 Billion
≈ $63.57 Million
Rs-644.00 Million
≈ $-6.96 Million
-0.110x -182.93%
2018-03-31 Rs5.53 Billion
≈ $59.83 Million
Rs730.90 Million
≈ $7.90 Million
0.132x -26.55%
2017-03-31 Rs5.31 Billion
≈ $57.46 Million
Rs955.66 Million
≈ $10.34 Million
0.180x +17.17%
2016-03-31 Rs5.17 Billion
≈ $55.96 Million
Rs794.30 Million
≈ $8.59 Million
0.154x -7.25%
2015-03-31 Rs5.95 Billion
≈ $64.30 Million
Rs983.98 Million
≈ $10.64 Million
0.166x +83.17%
2014-03-31 Rs7.25 Billion
≈ $78.43 Million
Rs655.29 Million
≈ $7.09 Million
0.090x +265.47%
2013-03-31 Rs8.53 Billion
≈ $92.30 Million
Rs-466.03 Million
≈ $-5.04 Million
-0.055x -161.11%
2012-03-31 Rs8.12 Billion
≈ $87.78 Million
Rs725.24 Million
≈ $7.84 Million
0.089x +193.19%
2011-03-31 Rs5.84 Billion
≈ $63.10 Million
Rs177.83 Million
≈ $1.92 Million
0.030x -69.08%
2010-03-31 Rs4.48 Billion
≈ $48.48 Million
Rs441.84 Million
≈ $4.78 Million
0.099x -64.25%
2009-03-31 Rs3.63 Billion
≈ $39.27 Million
Rs1.00 Billion
≈ $10.83 Million
0.276x +61.91%
2008-03-31 Rs3.33 Billion
≈ $36.06 Million
Rs567.77 Million
≈ $6.14 Million
0.170x +17.18%
2007-03-31 Rs3.11 Billion
≈ $33.68 Million
Rs452.62 Million
≈ $4.89 Million
0.145x +137.58%
2006-03-31 Rs1.92 Billion
≈ $20.80 Million
Rs117.63 Million
≈ $1.27 Million
0.061x --

About Ind-Swift Laboratories Limited

NSE:INDSWFTLAB India Drug Manufacturers - Specialty & Generic
Market Cap
$350.52 Million
Rs32.41 Billion INR
Market Cap Rank
#14207 Global
#703 in India
Share Price
Rs373.25
Change (1 day)
-1.32%
52-Week Range
Rs88.15 - Rs388.55
All Time High
Rs388.55
About

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hy… Read more